B
Bioventus Inc
NASDAQ:BVS
Bioventus Inc
NASDAQ:BVS
Price:
8.94
USD
-3.46%
Market Closed
Market Cap:
$739.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bioventus Inc
NASDAQ:BVS
|
US |
Balance Sheet
Balance Sheet Decomposition
Bioventus Inc
Bioventus Inc
Balance Sheet Decomposition is not available for
Bioventus Inc
Bioventus Inc
Balance Sheet
Bioventus Inc
Bioventus Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
16
|
5
|
43
|
65
|
87
|
44
|
32
|
37
|
42
|
51
|
|
| Cash |
16
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
43
|
65
|
87
|
44
|
32
|
37
|
42
|
51
|
|
| Total Receivables |
47
|
55
|
73
|
85
|
88
|
125
|
137
|
123
|
127
|
128
|
|
| Accounts Receivables |
47
|
55
|
73
|
85
|
88
|
125
|
137
|
123
|
127
|
128
|
|
| Other Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
27
|
35
|
27
|
27
|
29
|
62
|
85
|
91
|
92
|
82
|
|
| Other Current Assets |
6
|
5
|
5
|
6
|
8
|
33
|
18
|
17
|
14
|
11
|
|
| Total Current Assets |
95
|
99
|
148
|
183
|
212
|
263
|
273
|
268
|
276
|
273
|
|
| PP&E Net |
10
|
10
|
5
|
20
|
22
|
40
|
45
|
50
|
34
|
27
|
|
| PP&E Gross |
10
|
10
|
5
|
20
|
22
|
40
|
45
|
50
|
34
|
27
|
|
| Accumulated Depreciation |
9
|
14
|
19
|
18
|
20
|
23
|
31
|
41
|
50
|
54
|
|
| Intangible Assets |
274
|
319
|
237
|
217
|
192
|
695
|
1 039
|
482
|
405
|
368
|
|
| Goodwill |
50
|
59
|
50
|
50
|
50
|
148
|
14
|
7
|
7
|
7
|
|
| Long-Term Investments |
0
|
0
|
3
|
3
|
19
|
29
|
3
|
3
|
2
|
2
|
|
| Other Long-Term Assets |
1
|
1
|
0
|
0
|
0
|
51
|
0
|
0
|
5
|
6
|
|
| Other Assets |
50
|
59
|
50
|
50
|
50
|
148
|
14
|
7
|
7
|
7
|
|
| Total Assets |
430
N/A
|
487
+13%
|
443
-9%
|
472
+7%
|
495
+5%
|
1 226
+148%
|
1 373
+12%
|
811
-41%
|
728
-10%
|
684
-6%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
5
|
8
|
8
|
6
|
4
|
17
|
38
|
23
|
24
|
11
|
|
| Accrued Liabilities |
24
|
31
|
49
|
68
|
99
|
138
|
113
|
119
|
135
|
128
|
|
| Short-Term Debt |
0
|
24
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
8
|
14
|
5
|
10
|
15
|
18
|
33
|
29
|
28
|
16
|
|
| Other Current Liabilities |
15
|
10
|
3
|
5
|
4
|
8
|
120
|
5
|
23
|
5
|
|
| Total Current Liabilities |
52
|
88
|
65
|
89
|
123
|
181
|
304
|
175
|
210
|
160
|
|
| Long-Term Debt |
163
|
159
|
190
|
188
|
173
|
340
|
385
|
377
|
318
|
288
|
|
| Deferred Income Tax |
9
|
9
|
4
|
4
|
3
|
134
|
154
|
1
|
1
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
3
|
2
|
75
|
24
|
48
|
38
|
44
|
|
| Other Liabilities |
28
|
40
|
39
|
46
|
51
|
38
|
189
|
36
|
14
|
7
|
|
| Total Liabilities |
253
N/A
|
295
+17%
|
298
+1%
|
329
+11%
|
352
+7%
|
767
+118%
|
1 056
+38%
|
637
-40%
|
580
-9%
|
499
-14%
|
|
| Equity | |||||||||||
| Common Stock |
231
|
281
|
281
|
281
|
281
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
54
|
88
|
136
|
138
|
141
|
7
|
165
|
322
|
355
|
335
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
465
|
482
|
494
|
506
|
521
|
|
| Other Equity |
0
|
1
|
0
|
1
|
2
|
0
|
0
|
1
|
3
|
2
|
|
| Total Equity |
178
N/A
|
192
+8%
|
145
-24%
|
143
-2%
|
142
-1%
|
459
+223%
|
317
-31%
|
174
-45%
|
148
-15%
|
184
+24%
|
|
| Total Liabilities & Equity |
430
N/A
|
487
+13%
|
443
-9%
|
472
+7%
|
495
+5%
|
1 226
+148%
|
1 373
+12%
|
811
-41%
|
728
-10%
|
684
-6%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
56
|
56
|
56
|
56
|
56
|
75
|
78
|
79
|
82
|
69
|
|
Switch to:
Switch to:
See Also
Discover More
